Lupin Ltd. News and Updates

Name: Latest research reports of Lupin Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Lupin Ltd.
Rating: 3
Author: Geojit BNP Paribas

Keep track of all breaking news on Lupin Ltd. from all sources in a single place.

Load latest

Lupin Ltd.

29 Sep 2023

1996.00

1.48%

Lupin surges to 52-week high on receiving US FDA clearance for Nagpur unit

Moneycontrol

The US FDA classified Lupin's Nagpur unit as Voluntary Action Indicated.

Lupin Ltd. has an average target of 2329.44 from 9 brokers.

Lupin Ltd.

22 Sep 2023

1996.00

1.48%

Lupin to acquire five legacy brands from Menarini for Rs 101 crore

Business Line

The brands being acquired from the Italian pharma group span the therapeutic segments of gastroenterology, urology and anti-infectives

Number of FII/FPI investors increased from 964 to 979 in Mar 2025 qtr.

Lupin Ltd.

18 Sep 2023

1996.00

1.48%

Lupin Share Price Live blog for 18 Sep 2023

livemint

Lupin stock price went up today, 18 Sep 2023, by 0.94 %. The stock closed at 880.8 per share. The stock is currently trading at 889.05 per share. Investors should monitor Lupin stock price closely in the coming days and weeks to see how it reacts to the news.

Lupin Ltd. has an average target of 2329.44 from 9 brokers.

Lupin Ltd.

15 Sep 2023

1996.00

1.48%

Lupin share price Today Live Updates : Lupin Stock Rises as Investors Show Confidence

livemint

Lupin stock price went up today, 15 Sep 2023, by 0.94 %. The stock closed at 880.8 per share. The stock is currently trading at 889.05 per share. Investors should monitor Lupin stock price closely in the coming days and weeks to see how it reacts to the news.

Lupin Ltd. has an average target of 2329.44 from 9 brokers.

Lupin Ltd.

12 Sep 2023

1996.00

1.48%

Lupin gains 1.3% on business transfer agreement with subsidiary

Moneycontrol

Under the business transfer agreement, the pharma major will move the two active pharmaceutical ingredients (APIs) manufacturing sites at Dabhasa and Visakhapatnam to the subsidiary.

Number of FII/FPI investors increased from 964 to 979 in Mar 2025 qtr.

Lupin Ltd.

07 Sep 2023

1996.00

1.48%

Lupin Ltd partners with COPD, shares decline

Business Line

The shares were down by 0.27 per cent to Rs 1136.05 at 11.54 am on the BSE

Lupin Ltd. is trading below all available SMAs

Lupin initiative to improve access to pulmonary disease medication in US

Business Line | 07 Sep 2023 1 more

Lupin Ltd.

30 Aug 2023

1996.00

1.48%

Lupin gains on launching heart drug in Canada

Moneycontrol

Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin, launched Propranolol LA (long-acting) capsules of 60 mg, 80 mg, 120 mg and 160 mg, in Canada

Lupin Ltd. has an average target of 2329.44 from 9 brokers.

Lupin Ltd.

29 Aug 2023

1996.00

1.48%

Stocks to buy today: Lupin, Federal Bank among top 6 trading ideas

Economic Times

On the monthly options front, the maximum Call OI is placed at 19500 and then towards 19400 strikes while the maximum Put OI is placed at 19300 and then towards 19200 strikes.

Number of FII/FPI investors increased from 964 to 979 in Mar 2025 qtr.

Lupin Ltd.

25 Aug 2023

1996.00

1.48%

Lupin gets USFDA nod to market generic drug

Moneycontrol

The company has received approval from the US Food and Drug Administration (USFDA) to market Pirfenidone tablets in strengths of 267 mg and 801 mg, the Mumbai-based drug maker said in a statement.